Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
60.8M
-
Number of holders
-
173
-
Total shares
-
52.7M
-
Shares change
-
-1.45M
-
Total reported value, excl. options
-
$6.79B
-
Value change
-
-$260M
-
Put/Call ratio
-
1.04
-
Number of buys
-
102
-
Number of sells
-
-75
-
Price
-
$128.88
Significant Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q1 2021
186 filings reported holding ASND - Ascendis Pharma A/S - American Depositary Shares as of Q1 2021.
Ascendis Pharma A/S - American Depositary Shares (ASND) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7M shares
of 60.8M outstanding shares and own 86.58% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.41M shares), Artisan Partners Limited Partnership (6.05M shares), FMR LLC (5.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.07M shares), BAKER BROS. ADVISORS LP (3.54M shares), WELLINGTON MANAGEMENT GROUP LLP (3.49M shares), JANUS HENDERSON GROUP PLC (3.17M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.87M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.7M shares), and Vivo Capital, LLC (1.66M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.